Hepatitis B virus (HBV) isolates with A-1762 to T and G-1764 to A mutations in the core promoter have been associated with active hepatitis, severe liver disease following liver transplantation, hepatocellular carcinoma and acute fulminant courses -in the latter case combined with a C-1653 to T mutation. In this study, a mutant core promoter region containing the T-1653, T-1762 and A-1764 mutations was placed into the context of a wild-type HBV genome and analysed by transfection. The mutations reduced the level of pre-C mRNA (by 55 %) and e-antigen secretion. In contrast, no significant effects on the levels of pregenome/C and pre-S/S mRNAs, intracellular core, polymerase, and pre-S1/S2 proteins and secreted S-antigen were observed. The amount of progeny virus DNA in the cells and in the culture medium was increased marginally, if at all.
Hepatitis B virus (HBV) isolates with A-1762 to T and G-1764 to A mutations in the core promoter have been associated with active hepatitis, severe liver disease following liver transplantation, hepatocellular carcinoma and acute fulminant courses -in the latter case combined with a C-1653 to T mutation. In this study, a mutant core promoter region containing the T-1653, T-1762 and A-1764 mutations was placed into the context of a wild-type HBV genome and analysed by transfection. The mutations reduced the level of pre-C mRNA (by 55 %) and e-antigen secretion. In contrast, no significant effects on the levels of pregenome/C and pre-S/S mRNAs, intracellular core, polymerase, and pre-S1/S2 proteins and secreted S-antigen were observed. The amount of progeny virus DNA in the cells and in the culture medium was increased marginally, if at all.
Mutations in the core promoter\enhancer II (Cp\EnII) of hepatitis B virus (HBV), namely an A to T change at position 1762 combined with a G to A change at position 1764, were assumed to play a role in HBV pathogenesis. They were frequently observed in chronically infected patients with active liver disease, severe recurrent liver disease following liver transplantation or hepatocellular carcinoma, but not or rarely in asymptomatic hepatitis B e-antigen (HBeAg)-positive patients (Horikita et al., 1994 ; Okamoto et al., 1994 ; Takahashi et al., 1995 ; Hsia et al., 1996 ; Kurosaki et al., 1996 ; McMillan et al., 1996 ; Kidd-Ljunggren et al., 1997) . However, there is no strict association of these mutations with severe chronic hepatitis B as asymptomatic patients with anti-HBe in serum were also frequently found to be infected with such variants (Okamoto et al., 1994 ; Takahashi et al., 1995 ; Kurosaki et al., 1996) . Furthermore, some but not all studies on acutely infected patients reported an association of the T-1762\A-1764 mutations with fulminant courses (Kaneko et al., 1995 ; Laskus et al., 1995 ; Sato et al., 1995) . In these cases both mutations are frequently combined with a C to T exchange at position 1653 in the Cp\EnII (Ogata et al., 1993 ; Hasegawa et al., 1994 ; Kaneko et al., 1995) . In agreement with the prevalence of the T-1762\A-1764 variants in the different patient groups they emerge during HBeAg-to-anti-HBe seroconversion (Okamoto et al., 1994) , as also described for variants lacking HBeAg expression due to mutations in the pre-C region (Okamoto et al., 1990 ; Gu$ nther et al., 1992) . Since the T-1762\A-1764 mutations were not accompanied by such pre-C mutations in some HBeAg-seronegative and highly viraemic patients it was speculated that the core promoter mutations reduce HBeAg expression by decreasing the pre-C mRNA level (Okamoto et al., 1994) . These speculations were recently substantiated experimentally (Buckwold et al., 1996 ; Moriyama et al., 1996) . Interestingly, in addition to reduced pre-C mRNA and HBeAg levels the corresponding T-1762\A-1764 variants showed also enhanced replication. However, these studies attributed the enhanced replication to different mechanisms. In one study, an increased pregenome\C mRNA level was found (Moriyama et al., 1996) whereas in the other study only enhanced encapsidation but no increased concentration of this RNA was observed (Buckwold et al., 1996) . Therefore, further investigation is required to clarify the significance of these mutations.
We isolated HBV genomes with an intact pre-C region but with several mutations in the Cp\EnII, including T-1653, T-1762 and A-1764 (Fig. 1) , from an HBeAg-seronegative but highly viraemic patient. This study aimed at finding an explanation on a molecular level for the lack of HBeAg and high viraemia in this patient and at broadening the understanding of the significance of these frequently occurring 0001-5143 # 1998 SGM DHF Fig. 1 . Nucleotide sequences of the mutant (Mut) and wild-type (Wt) (Galibert et al., 1979) Cp/EnII fragments functionally analysed. Regulatory elements of the Cp/EnII (Yuh & Ting, 1991 ; Yuh et al., 1992) , the transcriptional start sites of the pre-C mRNA as determined by primer extension analysis (Fig. 2 A) and transcription factor binding sites (Lo! pez-Cabrera et al., 1990 ; Yuh & Ting, 1991 ; Chen et al., 1995 ; Raney et al., 1997) are shown.
mutations by detailed functional analysis of this mutant Cp\EnII region.
Full-length HBV genomes from serum 1\91 (HBsAg-and anti-HBe-positive, 50 pg HBV DNA\ml) of the previously described patient no. 9 (Gu$ nther et al., 1992) were amplified and cloned (Gu$ nther et al., 1995) . The Cp\EnII regions were sequenced and that of a representative mutant clone (positions 1571-1821) was placed within the context of a wild-type genome (Galibert et al., 1979) which is most closely related to the original HBV strain (Fig. 1 ). Virus transcription, protein synthesis and replication were analysed as described previously (Gu$ nther et al., 1996) . In brief, linear monomers of the mutant Cp\EnII hybrid genome and of the wild-type HBV genome were released from vector sequences and transfected into HuH7 cells using calcium phosphate precipitation. Cells were harvested after 4 days. For primer extension analysis total RNA was purified using the guanidinium-lysis method (Chomczynski & Sacchi, 1987) and 20 µg thereof was denatured and hybridized to 0n2 pmol $#P-labelled primer P1 (1991 ( -1973 . The primer was elongated with 5 U AMV reverse transcriptase (Promega) in the presence of 50 µg actinomycin D\ml and 1 U RNasin\µl (Promega). The reaction products were purified and separated in a 6 % polyacrylamide-7 M urea gel. For Northern blot analysis, 30 µg RNA was separated in a 1n5 % agaroseformaldehyde gel. RNA was blotted onto Hybond-N membranes (Amersham) and hybridized with a $#P-labelled fulllength HBV probe. To purify HBV DNA from cytoplasmic core particles cells were lysed with 1 % NP40 and the nuclei were removed by centrifugation. Viral particles from the cell culture medium were recovered by centrifugation at 45 000 r.p.m. for 4 h (Beckman SW50.1 rotor). Input DNA was removed with 100 µg DNase I\ml and proteins were digested with 0n5 mg proteinase K\ml. The released progeny HBV DNA was then phenol\chloroform-extracted and ethanolprecipitated. For Southern blot analysis HBV DNAs were separated on an 1n5 % agarose gel, blotted onto Hybond-N membranes and hybridized with a $#P-labelled full-length HBV probe. For immunoblot analysis cell lysates were separated by 17n5 % SDS-PAGE and transferred to a PVDF membrane (BioRad). Core protein was detected using polyclonal anti-HBc\e and pre-S proteins were detected using monoclonal anti-pre-S2 F52 (Immunotech). HBV polymerase protein was separated in a 10 % SDS-PAGE, blotted onto nitrocellulose membrane (Schleicher & Schuell) and detected using monoclonal anti-Pol 3.12F (unpublished).
The Cp\EnII mutations selectively decreased the pre-C mRNA level by 55 % as analysed by primer extension whereas the pregenome\C mRNA level was not affected (Fig. 2 A and Table 1 ). The level of HBeAg in the cell culture medium as determined by radio-immunoassay was significantly reduced by approximately 30 % which is slightly less than for the corresponding transcript (Fig. 2 E) . Since the amount of pre-C mRNA is low compared to the pregenome\C mRNA, Northern blot analysis of viral RNA revealed no significant change of the pre-C plus pregenome\C mRNA level ( Fig. 2 B and Table 1 ). Intracellular core and polymerase protein levels, as detected by immunoblotting (Fig. 2 F, G and Table 1) , and the levels of secreted HBsAg, as detected by enzymeimmunoassay (Fig. 2 E) , were only slightly elevated. A small reduction was observed in the levels of pre-S\S mRNAs and the pre-S\S : pre-C\C mRNA ratio, as determined by Northern blot analysis (Fig. 2 B and Table 1 ), as well as in the levels of the corresponding pre-S1\S2 proteins in the cells, as detected by immunoblotting (Fig. 2 H and Table 1 ). As expected from the barely changed levels of pregenome\C mRNA and proteins involved in replication and virion morphogenesis, the amount of replicative HBV DNA in viral particles from cells and from cell culture medium was only marginally, if at all, increased as determined by Southern blot analysis (Fig. 2 C, D Transfection efficiency was measured by co-transfection of a secreted alkaline phosphatase (SEAP) reporter plasmid and was found to be very similar for mutant and wild-type HBV which indicates that the viral DNA, RNA and protein data reflect the phenotype of the HBV genomes (Table 1) . Taken together, our observations suggest that the mutations in the Cp\EnII selectively decrease pre-C mRNA and HBeAg levels whereas they do not or only marginally affect the levels of all other major transcripts, viral proteins and replication. The reduced HBeAg expression may facilitate virus persistence in the presence of anti-HBe in the patient from whom the variant genome was derived.
Down-regulation of pre-C but not pregenome\C mRNA transcription initiation is most likely responsible for the changes in the steady-state transcript levels measured since a selective effect of the mutations on the half-life of only one of Autoradiography and chemiluminescence signals were quantified using TINA software (Raytest, Straubenhardt, Germany). Transfection efficiency was measured by co-transfection of a reporter plasmid expressing secreted alkaline phosphatase (SEAP) and determination of SEAP enzymatic activity in the cell culture supernatant (Cullen & Malim, 1992 these mRNAs is unlikely. Most recently published reports suggest that this effect is mediated by the A-1762 T and G-1764 A mutations (Buckwold et al., 1996 ; Moriyama et al., 1996) . However, the T-1753 C and G-1757 A mutations which are additionally present in our mutant Cp\EnII and are also frequently observed in other HBV strains alone or in combination with the T-1762\A-1764 mutations (Okamoto et al., 1994 ; Kidd-Ljunggren et al., 1995 Laskus et al., 1995 ; Kurosaki et al., 1996 ; McMillan et al., 1996) may co-determine the observed pre-C and C mRNA transcription pattern. The few mutations present in the upstream regulatory sequence (URS) of our promoter fragment are unlikely to exhibit a selective effect on one of the two core promoter transcripts because the URS regulates pre-C and C mRNA synthesis in a co-ordinate manner (Yuh et al., 1992) . Of particular interest is the C-1653 T mutation in the URS as it is usually combined with the T-1762\A-1764 mutations, associated with fulminant hepatitis (Ogata et al., 1993 ; Hasegawa et al., 1994 ; Kaneko et al., 1995) and located in the alpha box, which is a strongly activating element of both enhancer II and core promoter (Yuh & Ting, 1991 ; Yuh et al., 1992) . Interestingly, this mutation converts the alpha box binding site for C\EBP and related factors (Lo! pez-Cabrera et al., 1990 ; Yuh & Ting, 1991) into the perfect palindromic sequence 1648-TCTTATATAAGA, which could enhance binding affinity and thus Cp\EnII activity. However, the data presented clearly indicate that, at least in the sequence context analysed and in the cell line used, this mutation exerts, if at all, only a marginal effect on pregenome\C mRNA transcription and virus replication. This is consistent with previous data which indicated that even the duplication of the complete alpha box only leads to an approximately 30 % activation of the core promoter in HuH7 cells (Gu$ nther et al., 1996) . In conclusion, our data suggest that the effect of the T-1762\A-1764 mutations on pre-C mRNA expression is operative within the Cp\EnII sequence analysed here and predominantly determines its functional phenotype. Based on secondary structure predictions for the RNA pregenome it was previously speculated that the mutations at positions 1762\1764 and between 1751-1755 may also facilitate DNA minus-strand translocation to DR1 (Kidd & Kidd-Ljunggren, 1996 ; Kidd-Ljunggren et al., 1997) . If true, our data suggest that this has only a marginal effect on replication efficiency. Besides many consistent observations, our analysis also revealed discrepancies with the previous functional studies (Buckwold et al., 1996 ; Moriyama et al., 1996) . Most importantly, in both studies an approximately 3-fold increase in progeny virus DNA in the cells or in the cell culture supernatant was observed indicating strongly enhanced replication mediated by the T-1762\A-1764 mutations. In the analysis performed by Moriyama et al. (1996) enhanced replication was suggested to result from the observed 4-fold induction of the pregenome\C mRNA level. Furthermore, in this study the effect on the pre-C mRNA was much stronger (16-to 32-fold decrease) than observed in our analysis and, unlike in our study, HBsAg expression was also reduced which suggests an influence of the mutations on enhancer II function. The second study performed by Buckwold et al. (1996) found, DHI in agreement with our analysis and a CAT assay-based analysis (Nishizono et al., 1995) , no change in pregenome\C mRNA levels. Nevertheless, they found increased levels of secreted virion DNA and increased encapsidation of the pregenomic RNA. The authors offered reduced HBeAg precursor protein expression from the mutant virus as an explanation for enhanced encapsidation and virus production, a speculation based on the observation that overexpression of HBeAg precursor proteins can inhibit viral DNA synthesis in human hepatoma cells and in transgenic mice (Lamberts et al., 1993 ; Guidotti et al., 1996) , probably by interfering with viral capsid assembly in the cytoplasm (Scaglioni et al., 1997 b) . Although we observed a very similar level of pre-C mRNA reduction, such a mechanism is obviously not operative in our transfection system. This is in good agreement with several other studies in which complete lack of HBeAg precursor proteins was associated with no or only a marginal enhancement of pregenome encapsidation and replication (Tong et al., 1992 ; Hasegawa et al., 1994 ; Yuan et al., 1995 ; Miska, 1996) . The reason why some transfection studies revealed enhanced replication due to reduced precore protein expression (Buckwold et al., 1996 ; whereas others did not (Tong et al., 1992 ; Hasegawa et al., 1994 ; Yuan et al., 1995 ; Miska, 1996) is unclear. Hence, the in vivo significance of reduced or abrogated precore protein expression remains elusive. Studies with corresponding variants in in vivo or in vitro infection systems are required to clarify this point. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. Journal of Virology 71, 1058-1071.
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